抗抑郁药
人参
医学
药理学
传统医学
阿戈美拉汀
PI3K/AKT/mTOR通路
重性抑郁障碍
精神科
替代医学
信号转导
心情
生物
焦虑
病理
生物化学
出处
期刊:Cns & Neurological Disorders-drug Targets
[Bentham Science Publishers]
日期:2022-11-18
卷期号:22 (8): 1164-1175
被引量:9
标识
DOI:10.2174/1871527322666221116164836
摘要
OBJECTIVES: Blume (GEB), and reviewed the mechanisms underlying their antidepressant properties to provide a reference for the development of antidepressants and clinical medications. METHODS: An extensive range of medicinal, clinical, and chemistry databases and search engines were used for our literature search. We searched the literature using certain web literature search engines, including Google Scholar, PubMed, Science Direct, CNKI (China National Knowledge Infrastructure), and Web of Science. RESULTS: . Clinical investigations revealed that single or combined treatment of these medicines improved certain depressive symptoms. Antidepressant mechanisms are summarized based on this research. CONCLUSION: The antidepressant mechanism of these three medicines includes but is not limited to ameliorating inflammation within the brain, reversing the hypothalamic-pituitary adrenal axis (HPA) system hyperfunction, inhibiting monoamine neurotransmitters reuptake, anti-neuron apoptosis and preventing neurotoxicity, and regulating depressive-related pathways such as the BDNF pathway and the PI3K/Akt/mTOR pathway.
科研通智能强力驱动
Strongly Powered by AbleSci AI